[Combined infection of abdominal typhoid and hepatitis A and E].
Iu V
IuV
Lobzin
A N
AN
Kovalenko
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D019353:Endemic Diseases; D017957:Hepatitis A Virus, Human / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D016752:Hepatitis E virus / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D013620:Tajikistan / Q000453:epidemiology; D014435:Typhoid Fever / Q000150:complications / Q000175:diagnosis*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D012459:Salicylates; D002939:Ciprofloxacin; D015242:Ofloxacin